243 related articles for article (PubMed ID: 33582653)
1. A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation.
Zhang D; Wei X; Hong W; Fu L; Qian G; Xu AE
Aging (Albany NY); 2021 Feb; 13(4):5415-5425. PubMed ID: 33582653
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
[TBL] [Abstract][Full Text] [Related]
3. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
4. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
[TBL] [Abstract][Full Text] [Related]
5. Uncommon responses of segmental vitiligo to melanocyte-keratinocyte transplantation procedure.
Isedeh P; Al Issa A; Lim HW; Mulekar SS; Mulekar SV
J Cutan Med Surg; 2015; 19(2):177-81. PubMed ID: 25775633
[TBL] [Abstract][Full Text] [Related]
6. Lesional CD8+ T-Cell Number Predicts Surgical Outcomes of Melanocyte-Keratinocyte Transplantation Surgery for Vitiligo.
Refat MA; Strassner JP; Frisoli ML; Rashighi M; Richmond J; Nada E; Saleh R; El-Hamd MA; Goldberg D; Mahmoud BH; Harris JE
J Invest Dermatol; 2023 Nov; 143(11):2275-2282.e6. PubMed ID: 37478900
[TBL] [Abstract][Full Text] [Related]
7. Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review.
Maghfour J; Bardhi R; Huggins R; Hamzavi IH; Mohammad TF
Dermatology; 2023; 239(5):828-831. PubMed ID: 37231873
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of autologous non-cultured melanocyte keratinocyte transplantation in vitiligo and nevus depigmentosus.
Sritanyarat T; Wongpraparut C; Jansuwan N; Yothachai P; Nuntawisuttiwong N; Silpa-Archa N
J Dermatolog Treat; 2022 Mar; 33(2):935-940. PubMed ID: 32643482
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo.
Ramos MG; Ramos DG; Ramos CG
An Bras Dermatol; 2017; 92(3):312-318. PubMed ID: 29186240
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of noncultured melanocyte-keratinocyte transplant procedure for vitiligo and other leukodermas: a critical analysis of the evidence.
Vakharia PP; Lee DE; Khachemoune A
Int J Dermatol; 2018 Jul; 57(7):770-775. PubMed ID: 29318598
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
[TBL] [Abstract][Full Text] [Related]
12. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
[TBL] [Abstract][Full Text] [Related]
13. The Treatment of Refractory Vitiligo With Autologous Cultured Epithelium Grafting: A Real-World Retrospective Cohort Study.
Li J; Zeng X; Chen S; Tang L; Zhang Q; Lv M; Lian W; Wang J; Lv H; Liu Y; Shen J; Uyama T; Wu F; Wu J; Xu J
Stem Cells Transl Med; 2024 May; 13(5):415-424. PubMed ID: 38513284
[TBL] [Abstract][Full Text] [Related]
14. Fractional versus full ablative CO
Jamal-Edine AM; El-Barbary RA; Moftah NH
J Cosmet Dermatol; 2022 Apr; 21(4):1506-1513. PubMed ID: 34213808
[TBL] [Abstract][Full Text] [Related]
15. Dermabrasion Versus Microneedling in Transplantation of Autologous Noncultured Melanocyte-Keratinocyte Cell Suspension in Patients With Vitiligo.
Hasan MS; Almohsen AM; Nasr MI; Rageh MA
Dermatol Surg; 2023 May; 49(5):494-502. PubMed ID: 36892550
[TBL] [Abstract][Full Text] [Related]
16. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation.
Al Jasser MI; Ghwish B; Al Issa A; Mulekar SV
Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588
[TBL] [Abstract][Full Text] [Related]
17. Recipient site preparation by cryoblebbing in melanocyte keratinocyte transplantation procedure over the fingers in vitiligo: A pilot study.
El Hawary M; Bassiouny DA; Esmat S; Sobhi R; Saleh MA; AbdelHalim D; Hegazy R; Gawdat H; Ragab N; Samir N; Sany I
Dermatol Ther; 2020 Nov; 33(6):e14199. PubMed ID: 32798282
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Int J Dermatol; 2005 Oct; 44(10):841-5. PubMed ID: 16207186
[TBL] [Abstract][Full Text] [Related]
19. Genital vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV; Al Issa A; Al Eisa A; Asaad M
Dermatol Surg; 2005 Dec; 31(12):1737-9; discussion 1740. PubMed ID: 16336903
[TBL] [Abstract][Full Text] [Related]
20. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
